Avenda Health Raises $10M In Series B, Innovating Detection And Treatment For Prostate Cancer Care
08/25/22, 1:02 PM
Location
culver cityMoney raised
$10 million
Industry
medical
artificial intelligence
biotechnology
health care
Round Type
series b
Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, today announced it has raised $10M in Series B funding led by VCapital. The round also includes participation from Plug & Play Ventures and Wealthing VC Club. The capital will be used to accelerate the use of iQuest, an AI-enabled patient management software that identifies and visualizes a patient's prostate cancer. The funding will also be used to continue clinical evidence development.
Company Info
Location
4130 overland avenue
culver city, california, united states
Additional Info
In 2021, the company received Breakthrough Device Designation FDA clearance for the Avenda Health Focal Therapy System. Avenda Health has introduced technology that is innovating the men's health industry to improve treatment and cancer mapping for prostate cancer care. To better predict the extent of disease and support decision-making in cancer care, Avenda Health developed iQuest, which uses AI-deep learning to uncover cancer previously hidden within traditional MRI mapping and can be used by physicians to better plan treatments.